Skip to main content

Stephen L. Silvestro

Equibles does not estimate personal net worth.

Get an email with a short summary when OptimizeRx Corp publishes a filing, an earnings call transcript or a press release.

Get OPRX alerts

About Stephen L. Silvestro

Stephen L. Silvestro is recorded as Board Member at OptimizeRx Corp (OPRX) since June 20, 2025. OptimizeRx Corp reported in an 8-K filed June 24, 2025 that Stephen L. Silvestro was appointed director, effective June 20, 2025. OptimizeRx Corp reported in an 8-K filed October 25, 2023 that Stephen L. Silvestro was appointed President, effective October 24, 2023. OptimizeRx Corp reported in an 8-K filed October 16, 2023 that Stephen L. Silvestro was appointed President. The proxy statement of OptimizeRx Corp reports total compensation of $973,132 for Stephen L. Silvestro in fiscal 2024, including a base salary of $400,000. Disclosed compensation is on record for 7 fiscal years. OptimizeRx Corp is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at OptimizeRx Corp includes Stephen Silvestro (CEO and Board Member), William Febbo (CEO and Board Member), William J. Febbo (CEO and Board Member) and 7 others.

“Effective June 20, 2025, the Board increased the size of the Board to six (6) members and, upon the recommendation of the Board's Nominating & Governance Committee, appointed the Company's CEO Stephen Silvestro to serve as a director of the Company until the date of the Company's 2026 annual meeting of stockholders and until his successor is elected and qualified, except in the event of his earlier death, resignation or removal.”
OptimizeRx Corp Form 8-K, filed June 24, 2025 · Read the filing
“As previously disclosed, the Board determined to appoint Stephen L. Silvestro President of the Company effective as of the closing of the Merger.”
OptimizeRx Corp Form 8-K, filed October 25, 2023 · Read the filing

Affiliation history

Company network

Current role

Health Information Services · Healthcare

Board Member

2023-10-24–present

Leadership on record at OptimizeRx Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 OptimizeRx Corp (OPRX) $400,000 $973,132
2023 OptimizeRx Corp (OPRX) $384,583 $970,357
2022 OptimizeRx Corp (OPRX) $350,000 $1,558,637
2021 OptimizeRx Corp (OPRX) $330,000 $1,243,902
2020 OptimizeRx Corp (OPRX) $300,000 $866,190
2019 OptimizeRx Corp (OPRX) $188,821 $1,120,199
2018 OptimizeRx Corp (OPRX) — —

Recent activity